Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Short Bowel Syndrome as the Leading Cause of Intestinal Failure in Early Life: Some Insights into the Management

  • Goulet, Olivier (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School) ;
  • Nader, Elie Abi (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School) ;
  • Pigneur, Benedicte (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School) ;
  • Lambe, Cecile (Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hopital Necker-Enfants Malades, University Sorbonne-Paris-Cite Paris Descartes Medical School)
  • Received : 2019.03.26
  • Accepted : 2019.05.11
  • Published : 2019.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Intestinal failure (IF) is the critical reduction of the gut mass or its function below the minimum needed to absorb nutrients and fluids required for adequate growth in children. Severe IF requires parenteral nutrition (PN). Pediatric IF is most commonly due to congenital or neonatal intestinal diseases or malformations divided into 3 groups: 1) reduced intestinal length and consequently reduced absorptive surface, such as in short bowel syndrome (SBS) or extensive aganglionosis; 2) abnormal development of the intestinal mucosa such as congenital diseases of enterocyte development; 3) extensive motility dysfunction such as chronic intestinal pseudo-obstruction syndromes. The leading cause of IF in childhood is the SBS. In clinical practice the degree of IF may be indirectly measured by the level of PN required for normal or catch up growth. Other indicators such as serum citrulline have not proven to be highly reliable prognostic factors in children. The last decades have allowed the development of highly sophisticated nutrient solutions consisting of optimal combinations of macronutrients and micronutrients as well as guidelines, promoting PN as a safe and efficient feeding technique. However, IF that requires long-term PN may be associated with various complications including infections, growth failure, metabolic disorders, and bone disease. IF Associated Liver Disease may be a limiting factor. However, changes in the global management of IF pediatric patients, especially since the setup of intestinal rehabilitation centres did change the prognosis thus limiting "nutritional failure" which is considered as a major indication for intestinal transplantation (ITx) or combined liver-ITx.

Keywords

References

  1. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 2006;130:S16-28. https://doi.org/10.1053/j.gastro.2005.12.002
  2. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, et al.; Parenteral Nutrition Guidelines Working Group 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005;41 Suppl 2:S1-87. https://doi.org/10.1097/01.scs.0000180283.05624.bf
  3. Mihatsch W, Shamir R, van Goudoever JB, Fewtrell M, Lapillonne A, Lohner S, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: guideline development process for the updated guidelines. Clin Nutr 2018;37:2306-8. https://doi.org/10.1016/j.clnu.2018.06.943
  4. Abi Nader E, Lambe C, Talbotec C, Dong L, Pigneur B, Goulet O. A new concept to achieve optimal weight gain in malnourished infants on total parenteral nutrition. JPEN J Parenter Enteral Nutr 2018;42:78-86.
  5. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-505. https://doi.org/10.1053/gast.2000.20227
  6. Bailly-Botuha C, Colomb V, Thioulouse E, Berthe MC, Garcette K, Dubern B, et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res 2009;65:559-63. https://doi.org/10.1203/PDR.0b013e31819986da
  7. Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. Eur J Gastroenterol 2018;6:181-91. https://doi.org/10.1177/2050640617737632
  8. Abi Nader E, Lambe C, Talbotec C, Pigneur B, Lacaille F, Garnier-Lengline H, et al. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center. Am J Clin Nutr 2016;103:1327-36. https://doi.org/10.3945/ajcn.115.121756
  9. D'Antiga L, Goulet O. Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr 2013;56:118-26. https://doi.org/10.1097/MPG.0b013e318268a9e3
  10. Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 2009;14:256-61. https://doi.org/10.1097/MOT.0b013e32832ac06f
  11. Kaufman SS, Pehlivanova M, Fennelly EM, Rekhtman YM, Gondolesi GE, Little CA, et al. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr 2010;156:580-585.e1. https://doi.org/10.1016/j.jpeds.2009.11.002
  12. Pichler J, Horn V, Macdonald S, Hill S. Intestinal failure-associated liver disease in hospitalised children. Arch Dis Child 2012;97:211-4. https://doi.org/10.1136/archdischild-2011-300274
  13. Goulet O, Lambe C. Intravenous lipid emulsions in pediatric patients with intestinal failure. Curr Opin Organ Transplant 2017;22:142-8. https://doi.org/10.1097/MOT.0000000000000396
  14. Velazco CS, Fullerton BS, Brazzo JA 3rd, Hong CR, Jaksic T, Barnewolt CE. Radiographic measurement of intestinal length among children with short bowel syndrome: retrospective determination remains problematic. J Pediatr Surg 2017;52:1921-4. https://doi.org/10.1016/j.jpedsurg.2017.08.055
  15. Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut 1991;32:1321-3. https://doi.org/10.1136/gut.32.11.1321
  16. Struijs MC, Diamond IR, de Silva N, Wales PW. Establishing norms for intestinal length in children. J Pediatr Surg 2009;44:933-8. https://doi.org/10.1016/j.jpedsurg.2009.01.031
  17. Ricour C, Duhamel JF, Arnaud-Battandier F, Collard Y, Revillon Y, Nihoul-Fekete C. Enteral and parenteral nutrition in the short bowel syndrome in children. World J Surg 1985;9:310-5. https://doi.org/10.1007/BF01656325
  18. Goulet OJ, Revillon Y, Jan D, De Potter S, Maurage C, Lortat-Jacob S, et al. Neonatal short bowel syndrome. J Pediatr 1991;119:18-23. https://doi.org/10.1016/S0022-3476(05)81032-7
  19. Iacono G, Carroccio A, Montalto G, Cavataio F, Lo Cascio M, Notarbatolo A. Extreme short bowel syndrome: a case for reviewing the guidelines for predicting survival. J Pediatr Gastroenterol Nutr 1993;16:216-9. https://doi.org/10.1097/00005176-199302000-00023
  20. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33. https://doi.org/10.1067/mpd.2001.114481
  21. Quiros-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004;145:157-63. https://doi.org/10.1016/j.jpeds.2004.02.030
  22. Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005;15:95-101. https://doi.org/10.1055/s-2004-821214
  23. Sala D, Chomto S, Hill S. Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus. Transplant Proc 2010;42:5-8. https://doi.org/10.1016/j.transproceed.2009.12.033
  24. Nusinovich Y, Revenis M, Torres C. Long-term outcomes for infants with intestinal atresia studied at Children's National Medical Center. J Pediatr Gastroenterol Nutr 2013;57:324-9. https://doi.org/10.1097/MPG.0b013e318299fd9f
  25. Belza C, Fitzgerald K, de Silva N, Avitzur Y, Steinberg K, Courtney-Martin G, et al. Predicting intestinal adaptation in pediatric intestinal failure: a retrospective cohort study. Ann Surg 2019;269:988-93. https://doi.org/10.1097/SLA.0000000000002602
  26. Khen-Dunlop N, Sarnacki S, Victor A, Grosos C, Menard S, Soret R, et al. Prenatal intestinal obstruction affects the myenteric plexus and causes functional bowel impairment in fetal rat experimental model of intestinal atresia. PLoS One 2013;8:e62292. https://doi.org/10.1371/journal.pone.0062292
  27. Urla C, Lieber J, Obermayr F, Busch A, Schweizer R, Warmann SW, et al. Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome. BMC Surg 2018;18:58. https://doi.org/10.1186/s12893-018-0383-6
  28. Goulet O, Olieman J, Ksiazyk J, Spolidoro J, Tibboe D, Kohler H, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr 2013;32:162-71. https://doi.org/10.1016/j.clnu.2012.09.007
  29. Parvadia JK, Keswani SG, Vaikunth S, Maldonado AR, Marwan A, Stehr W, et al. Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol 2007;293:G591-8. https://doi.org/10.1152/ajpgi.00572.2006
  30. Helmrath MA, Shin CE, Fox JW, Erwin CR, Warner BW. Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor. Surgery 1998;124:848-54. https://doi.org/10.1016/S0039-6060(98)70008-X
  31. Olieman JF, Penning C, Ijsselstijn H, Escher JC, Joosten KF, Hulst JM, et al. Enteral nutrition in children with short-bowel syndrome: current evidence and recommendations for the clinician. J Am Diet Assoc 2010;110:420-6. https://doi.org/10.1016/j.jada.2009.12.001
  32. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 2012;96:544-51. https://doi.org/10.3945/ajcn.112.037382
  33. Capriati T, Nobili V, Stronati L, Cucchiara S, Laureti F, Liguori A, et al. Enteral nutrition in pediatric intestinal failure: does initial feeding impact on intestinal adaptation? Expert Rev Gastroenterol Hepatol 2017;11:741-8. https://doi.org/10.1080/17474124.2017.1335196
  34. Mezoff EA, Hawkins JA, Ollberding NJ, Karns R, Morrow AL, Helmrath MA. The human milk oligosaccharide 2′-fucosyllactose augments the adaptive response to extensive intestinal. Am J Physiol Gastrointest Liver Physiol 2016;310:G427-38. https://doi.org/10.1152/ajpgi.00305.2015
  35. de Boissieu D, Dupont C. Allergy to extensively hydrolyzed cow's milk proteins in infants: safety and duration of amino acid-based formula. J Pediatr 2002;141:271-3. https://doi.org/10.1067/mpd.2002.126299
  36. Diamanti A, Fiocchi AG, Capriati T, Panetta F, Pucci N, Bellucci F, et al. Cow's milk allergy and neonatal short bowel syndrome: comorbidity or true association? Eur J Clin Nutr 2015;69:102-6. https://doi.org/10.1038/ejcn.2014.156
  37. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998;26:123-8. https://doi.org/10.1097/00005176-199802000-00001
  38. De Greef E, Mahler T, Janssen A, Cuypers H, Veereman-Wauters G. The influence of neocate in paediatric short bowel syndrome on PN weaning. J Nutr Metab 2010;2010:297575.
  39. Norsa L, Lambe C, Abi Abboud S, Barbot-Trystram L, Ferrari A, Talbotec C, et al.. The colon as an energy salvage organ for children with short bowel syndrome. Am J Clin Nutr 2019;109:1112-8. https://doi.org/10.1093/ajcn/nqy367
  40. Tappenden KA, Thomson AB, Wild GE, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology 1997;112:792-802. https://doi.org/10.1053/gast.1997.v112.pm9041241
  41. Bartholome AL, Albin DM, Baker DH, Holst JJ, Tappenden KA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr 2004;28:210-22. https://doi.org/10.1177/0148607104028004210
  42. Reigstad CS, Salmonson CE, Rainey JF 3rd, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015;29:1395-403. https://doi.org/10.1096/fj.14-259598
  43. Koruda MJ, Rolandelli RH, Settle RG, Zimmaro DM, Rombeau JL. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology 1988;95:715-20. https://doi.org/10.1016/S0016-5085(88)80019-2
  44. Mayeur C, Gratadoux JJ, Bridonneau C, Chegdani F, Larroque B, Kapel N, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One 2013;8:e54335. https://doi.org/10.1371/journal.pone.0054335
  45. Joly F, Mayeur C, Messing B, Lavergne-Slove A, Cazals-Hatem D, Noordine ML, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2009;297:G116-23. https://doi.org/10.1152/ajpgi.90657.2008
  46. Kaneko T, Bando Y, Kurihara H, Satomi K, Nonoyama K, Matsuura N. Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli. J Clin Microbiol 1997;35:3181-5. https://doi.org/10.1128/JCM.35.12.3181-3185.1997
  47. Engstrand Lilja H, Wefer H, Nystrom N, Finkel Y, Engstrand L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome 2015;3:18. https://doi.org/10.1186/s40168-015-0084-7
  48. Davidovics ZH, Carter BA, Luna RA, Hollister EB, Shulman RJ, Versalovic J. The fecal microbiome in pediatric patients with short bowel syndrome. JPEN J Parenter Enteral Nutr 2016;40:1106-13. https://doi.org/10.1177/0148607115591216
  49. Kadakia SC. D-lactic acidosis in a patient with jejunoileal bypass. J Clin Gastroenterol 1995;20:154-6. https://doi.org/10.1097/00004836-199503000-00019
  50. Petersen C. D-lactic acidosis. Nutr Clin Pract 2005;20:634-45. https://doi.org/10.1177/0115426505020006634
  51. Hudson M, Pocknee R, Mowat NA. D-lactic acidosis in short bowel syndrome--an examination of possible mechanisms. Q J Med 1990;74:157-63.
  52. Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004;39:634-6. https://doi.org/10.1016/j.jpedsurg.2003.12.026
  53. Takahashi K, Terashima H, Kohno K, Ohkohchi N. A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome. Int Surg 2013;98:110-3. https://doi.org/10.9738/CC169
  54. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med 1995;122:839-42. https://doi.org/10.7326/0003-4819-122-11-199506010-00005
  55. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999;11:141-61. https://doi.org/10.1046/j.1365-2982.1999.00147.x
  56. Cole CR, Frem JC, Schmotzer B, Gewirtz AT, Meddings JB, Gold BD, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr 2010;156:941-947.e1. https://doi.org/10.1016/j.jpeds.2009.12.008
  57. Gutierrez IM, Kang KH, Calvert CE, Johnson VM, Zurakowski D, Kamin D, et al. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg 2012;47:1150-4. https://doi.org/10.1016/j.jpedsurg.2012.03.019
  58. Quigley EMM. The spectrum of small intestinal bacterial overgrowth (SIBO). Curr Gastroenterol Rep 2019;21:3. https://doi.org/10.1007/s11894-019-0671-z
  59. Triantafyllou K, Sioulas AD, Giamarellos-Bourboulis EJ. Rifaximin: the revolutionary antibiotic approach for irritable bowel syndrome. Mini Rev Med Chem 2015;16:186-92. https://doi.org/10.2174/1389557515666150722105340
  60. Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, et al. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol 2013;8:169-72. https://doi.org/10.2174/15748847113089990048
  61. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005;40:755-62. https://doi.org/10.1016/j.jpedsurg.2005.01.037
  62. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr 2012;161:723-728.e2. https://doi.org/10.1016/j.jpeds.2012.03.062
  63. Hukkinen M, Mutanen A, Pakarinen MP. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury. Surgery 2017;162:670-9. https://doi.org/10.1016/j.surg.2017.04.018
  64. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010;34:32-7. https://doi.org/10.1177/0148607109332772
  65. Hukkinen M, Kivisaari R, Merras-Salmio L, Koivusalo A, Pakarinen MP Small bowel dilatation predicts prolonged parenteral nutrition and decreased survival in pediatric short bowel syndrome. Ann Surg 2017;266:369-75. https://doi.org/10.1097/SLA.0000000000001893
  66. Moseley RH. Sepsis and cholestasis. Clin Liver Dis 2004;8:83-94. https://doi.org/10.1016/S1089-3261(03)00134-X
  67. Jones A, Selby PJ, Viner C, Hobbs S, Gore ME, McElwain TJ. Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 1990;31:938-9. https://doi.org/10.1136/gut.31.8.938
  68. Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006;3:574-85. https://doi.org/10.1038/ncpgasthep0602
  69. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007;44:459-63. https://doi.org/10.1097/MPG.0b013e318031a5c7
  70. Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol 2009;51:565-80. https://doi.org/10.1016/j.jhep.2009.05.012
  71. El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology 2012;55:1518-28. https://doi.org/10.1002/hep.25500
  72. McKenna S, Gossling M, Bugarini A, Hill E, Anderson AL, Rancourt RC, et al. Endotoxemia induces $I{\kappa}B{\beta}$/NF-${\kappa}B$-dependent endothelin-1 expression in hepatic macrophages. J Immunol 2015;195:3866-79. https://doi.org/10.4049/jimmunol.1501017
  73. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000;24:345-50. https://doi.org/10.1177/0148607100024006345
  74. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32.
  75. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998;14:158-64. https://doi.org/10.1016/S0899-9007(97)00233-5
  76. Forchielli ML, Bersani G, Tala S, Grossi G, Puggioli C, Masi M. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids 2010;45:63-71. https://doi.org/10.1007/s11745-009-3371-x
  77. Wanten G, Beunk J, Naber A, Swinkels D. Tocopherol isoforms in parenteral lipid emulsions and neutrophil activation. Clin Nutr 2002;21:417-22. https://doi.org/10.1054/clnu.2002.0570
  78. Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000;19:177-84. https://doi.org/10.1054/clnu.1999.0096
  79. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197-201. https://doi.org/10.1542/peds.2005-2662
  80. Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg 2010;45:84-7. https://doi.org/10.1016/j.jpedsurg.2009.10.014
  81. Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr 2016;103:629S-634S. https://doi.org/10.3945/ajcn.114.103986
  82. Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr 2012;36:81S-94S. https://doi.org/10.1177/0148607111424411
  83. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010;51:514-21. https://doi.org/10.1097/MPG.0b013e3181de210c
  84. Deshpande G, Simmer K, Deshmukh M, Mori TA, Croft KD, Kristensen J. Fish oil (SMOFlipid) and olive oil lipid (Clinoleic) in very preterm neonates. J Pediatr Gastroenterol Nutr 2014;58:177-82. https://doi.org/10.1097/MPG.0000000000000174
  85. Goulet O, Antebi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010;34:485-95. https://doi.org/10.1177/0148607110363614
  86. Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 2012;54:797-802. https://doi.org/10.1097/MPG.0b013e3182447daf
  87. Anez-Bustillos L, Dao DT, Fell GL, Baker MA, Gura KM, Bistrian BR, et al. Redefining essential fatty acids in the era of novel intravenous lipid emulsions. Clin Nutr 2018;37:784-9. https://doi.org/10.1016/j.clnu.2017.07.004
  88. Baker MA, Mitchell PD, O'Loughlin AA, Potemkin AK, Anez-Bustillos L, Dao DT, et al. Characterization of fatty acid profiles in infants with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr 2018;42:71-7.
  89. Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr 2018;37:2324-36. https://doi.org/10.1016/j.clnu.2018.06.946
  90. Charbit-Henrion F, Chardot C, Ruemmele F, Talbotec C, Morali A, Goulet O, et al. Anastomotic ulcerations after intestinal resection in infancy. J Pediatr Gastroenterol Nutr 2014;59:531-6. https://doi.org/10.1097/MPG.0000000000000472
  91. Fremond ML, Viala J, Treton X, Roy M, Berrebi D, Gottrand F, et al. Digestive perianastomotic ulcerations and Crohn's disease. J Crohns Colitis 2014;8:1624-31. https://doi.org/10.1016/j.crohns.2014.06.011
  92. Bianchi A. Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr Surg 1980;15:145-51. https://doi.org/10.1016/S0022-3468(80)80005-4
  93. Kim HB, Lee PW, Garza J, Duggan C, Fauza D, Jaksic T. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003;38:881-5. https://doi.org/10.1016/S0022-3468(03)00115-5
  94. Sudan D, Thompson J, Botha J, Grant W, Antonson D, Raynor S, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007;246:593-601. https://doi.org/10.1097/SLA.0b013e318155aa0c
  95. Bianchi A, Morabito A. The dilated bowel: a liability and an asset. Semin Pediatr Surg 2009;18:249-57. https://doi.org/10.1053/j.sempedsurg.2009.07.010
  96. Modi BP, Javid PJ, Jaksic T, Piper H, Langer M, Duggan C, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007;204:365-71. https://doi.org/10.1016/j.jamcollsurg.2006.12.033
  97. Thompson J, Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg 2008;42:49-61. https://doi.org/10.1016/j.yasu.2008.03.009
  98. Ramos-Gonzalez G, Kim HB. Autologous intestinal reconstruction surgery. Semin Pediatr Surg 2018;27:261-6. https://doi.org/10.1053/j.sempedsurg.2018.08.001
  99. Barrett M, Demehri FR, Ives GC, Schaedig K, Arnold MA, Teitelbaum DH. Taking a STEP back: assessing the outcomes of multiple STEP procedures. J Pediatr Surg 2017;52:69-73. https://doi.org/10.1016/j.jpedsurg.2016.10.024
  100. Oliveira C, de Silva N, Wales PW. Five-year outcomes after serial transverse enteroplasty in children with short bowel syndrome. J Pediatr Surg 2012;47:931-7. https://doi.org/10.1016/j.jpedsurg.2012.01.049
  101. Mutanen A, Barrett M, Feng Y, Lohi J, Rabah R, Teitelbaum DH, et al. Short bowel mucosal morphology, proliferation and inflammation at first and repeat STEP procedures. J Pediatr Surg 2019;54:511-6. https://doi.org/10.1016/j.jpedsurg.2018.04.016
  102. Ziegler MM, Royal RE, Brandt J, Drasnin J, Martin LW. Extended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis. Ann Surg 1993;218:504-9. https://doi.org/10.1097/00000658-199310000-00010
  103. Fusaro F, Morini F, Mutanen A, De Angelis P, Tambucci R, Capriati T, et al. Autologous intestinal reconstructive surgery in the management of total intestinal aganglionosis. J Pediatr Gastroenterol Nutr 2019;68:635-41. https://doi.org/10.1097/MPG.0000000000002260
  104. Matarese LE, Abu-Elmagd K. Somatropin for the treatment of short bowel syndrome in adults. Expert Opin Pharmacother 2005;6:1741-50. https://doi.org/10.1517/14656566.6.10.1741
  105. Goulet O, Dabbas-Tyan M, Talbotec C, Kapel N, Rosilio M, Souberbielle JC, et al. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome. JPEN J Parenter Enteral Nutr 2010;34:513-20. https://doi.org/10.1177/0148607110362585
  106. Peretti N, Loras-Duclaux I, Kassai B, Restier-Miron L, Guimber D, Gottrand F, et al. Growth hormone to improve short bowel syndrome intestinal autonomy: a pediatric randomized open-label clinical trial. JPEN J Parenter Enteral Nutr 2011;35:723-31. https://doi.org/10.1177/0148607111415531
  107. Wales PW, Nasr A, de Silva N, Yamada J. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 2010:CD006321.
  108. Jeppesen PB. Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Curr Opin Endocrinol Diabetes Obes 2015;22:14-20. https://doi.org/10.1097/MED.0000000000000120
  109. Wilhelm SM, Lipari M, Kulik JK, Kale-Pradhan PB. Teduglutide for the treatment of short bowel syndrome. Ann Pharmacother 2014;48:1209-13. https://doi.org/10.1177/1060028014537468
  110. Carter BA, Cohran VC, Cole CR, Corkins MR, Dimmitt RA, Duggan C, et al. Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr 2017;181:102-111.e5. https://doi.org/10.1016/j.jpeds.2016.10.027
  111. Ben Lulu S, Coran AG, Shehadeh N, Shamir R, Mogilner JG, Sukhotnik I. Oral insulin stimulates intestinal epithelial cell turnover following massive small bowel resection in a rat and a cell culture model. Pediatr Surg Int 2012;28:179-87. https://doi.org/10.1007/s00383-011-2991-4
  112. Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2009;28:88-93. https://doi.org/10.1016/j.clnu.2008.11.002
  113. McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 2010;19:35-43. https://doi.org/10.1053/j.sempedsurg.2009.11.010
  114. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005;242:403-9. https://doi.org/10.1097/00000658-200509000-00011
  115. Nucci A, Burns RC, Armah T, Lowery K, Yaworski JA, Strohm S, et al. Interdisciplinary management of pediatric intestinal failure: a 10-year review of rehabilitation and transplantation. J Gastrointest Surg 2008;12:429-35. https://doi.org/10.1007/s11605-007-0444-0
  116. Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009;19:348-53. https://doi.org/10.1055/s-0029-1241865
  117. Fullerton BS, Hong CR, Jaksic T. Long-term outcomes of pediatric intestinal failure. Semin Pediatr Surg 2017;26:328-35. https://doi.org/10.1053/j.sempedsurg.2017.09.006
  118. Merritt RJ, Cohran V, Raphael BP, Sentongo T, Volpert D, Warner BW, et al. Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome. J Pediatr Gastroenterol Nutr 2017;65:588-96. https://doi.org/10.1097/MPG.0000000000001722
  119. Totonelli G, Tambucci R, Boscarelli A, Hermans D, Dall'Oglio L, Diamanti A, et al. Pediatric intestinal rehabilitation and transplantation registry: initial report from a European Collaborative Registry. Eur J Pediatr Surg 2018;28:75-80. https://doi.org/10.1055/s-0037-1605349
  120. Lambe C, Poisson C, Talbotec C, Goulet O. Strategies to reduce catheter-related bloodstream infections in pediatric patients receiving home parenteral nutrition: the efficacy of taurolidine-citrate prophylactic-locking. JPEN J Parenter Enteral Nutr 2018;42:1017-25. https://doi.org/10.1002/jpen.1043
  121. Kawano T, Kaji T, Onishi S, Yamada K, Yamada W, Nakame K, et al. Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment. Pediatr Surg Int 2016;32:863-7. https://doi.org/10.1007/s00383-016-3933-y
  122. Smith JM, Weaver T, Skeans MA, Horslen SP, Harper AM, Snyder JJ, et al. OPTN/SRTR 2016 annual data report: intestine. Am J Transplant 2018;18 Suppl 1:254-90. https://doi.org/10.1111/ajt.14560
  123. Moreno Villares J, Galiano Segovia MJ, Marin Ferrer M. Changes in feeding behavior of patients who had received enteral nutrition during the 1st year of life. Nutr Hosp 1998;13:90-4.
  124. Krom H, de Winter JP, Kindermann A. Development, prevention, and treatment of feeding tube dependency. Eur J Pediatr 2017;176:683-8. https://doi.org/10.1007/s00431-017-2908-x
  125. Wilken M, Cremer V, Berry J, Bartmann P. Rapid home-based weaning of small children with feeding tube dependency: positive effects on feeding behaviour without deceleration of growth. Arch Dis Child 2013;98:856-61. https://doi.org/10.1136/archdischild-2012-303558
  126. Hopkins J, Cermak SA, Merritt RJ. Oral feeding difficulties in children with short bowel syndrome: a narrative review. Nutr Clin Pract 2017:884533617707493.
  127. Chiatto F, Coletta R, Aversano A, Warburton T, Forsythe L, Morabito A. Messy play therapy in the treatment of food aversion in a patient with intestinal failure: our experience. JPEN J Parenter Enteral Nutr 2019;43:412-8. https://doi.org/10.1002/jpen.1433
  128. Leonberg BL, Chuang E, Eicher P, Tershakovec AM, Leonard L, Stallings VA. Long-term growth and development in children after home parental nutrition. J Pediatr 1998;132:461-6. https://doi.org/10.1016/S0022-3476(98)70021-6
  129. Olieman JF, Tibboel D, Penning C. Growth and nutritional aspects of infantile short bowel syndrome for the past 2 decades. J Pediatr Surg 2008;43:2061-9. https://doi.org/10.1016/j.jpedsurg.2008.04.017
  130. Wu J, Tang Q, Feng Y, Huang J, Tao Y, Wang Y, et al. Nutrition assessment in children with short bowel syndrome weaned off parenteral nutrition: a long-term follow-up study. J Pediatr Surg 2007;42:1372-6. https://doi.org/10.1016/j.jpedsurg.2007.03.036
  131. Kimura O, Ono S, Furukawa T, Higuchi K, Deguchi E, Iwai N. Management strategies for infants with total intestinal aganglionosis. J Pediatr Surg 2009;44:1564-7. https://doi.org/10.1016/j.jpedsurg.2008.11.050
  132. Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Revillon Y, Jan D, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr 2007;44:347-53. https://doi.org/10.1097/MPG.0b013e31802c6971
  133. Gandullia P, Lugani F, Costabello L, Arrigo S, Calvi A, Castellano E, et al. Long-term home parenteral nutrition in children with chronic intestinal failure: a 15-year experience at a single Italian centre. Dig Liver Dis 2011;43:28-33. https://doi.org/10.1016/j.dld.2010.04.012
  134. Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011;60:17-25. https://doi.org/10.1136/gut.2010.223255
  135. Wiskin AE, Cole C, Owens DR, Morgan M, Burge DM, Beattie RM. Ten-year experience of home parenteral nutrition in a single centre. Acta Paediatr 2012;101:524-7. https://doi.org/10.1111/j.1651-2227.2012.02594.x
  136. Lezo A, Capriati T, Spagnuolo MI, Lacitignola L, Goreva I, Di Leo G, et al. Paediatric home artificial nutrition in Italy: report from 2016 survey on behalf of artificial nutrition network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). Nutrients 2018;10:E1311. https://doi.org/10.3390/nu10091311
  137. Barclay AR, Henderson P, Gowen H, Puntis J; BIFS collaborators. The continued rise of paediatric home parenteral nutrition use: implications for service and the improvement of longitudinal data collection. Clin Nutr 2015;34:1128-32. https://doi.org/10.1016/j.clnu.2014.11.009
  138. Petit LM, Girard D, Ganousse-Mazeron S, Talbotec C, Pigneur B, Elie C, et al. Weaning off prognosis factors of home parenteral nutrition for children with primary digestive disease. J Pediatr Gastroenterol Nutr 2016;62:462-8. https://doi.org/10.1097/MPG.0000000000000980
  139. Diamanti A, Conforti A, Panetta F, Torre G, Candusso M, Bagolan P, et al. Long-term outcome of home parenteral nutrition in patients with ultra-short bowel syndrome. J Pediatr Gastroenterol Nutr 2014;58:438-42. https://doi.org/10.1097/MPG.0000000000000242
  140. Ganousse-Mazeron S, Lacaille F, Colomb-Jung V, Talbotec C, Ruemmele F, Sauvat F, et al. Assessment and outcome of children with intestinal failure referred for intestinal transplantation. Clin Nutr 2015;34:428-35. https://doi.org/10.1016/j.clnu.2014.04.015
  141. Hill S, Ksiazyk J, Prell C, Tabbers M, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: home parenteral nutrition. Clin Nutr 2018;37:2401-8. https://doi.org/10.1016/j.clnu.2018.06.954
  142. Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005;9:165-76. https://doi.org/10.1016/j.gassur.2004.10.014
  143. Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007;45:204-12. https://doi.org/10.1097/MPG.0b013e31805905f9
  144. Beath S, Pironi L, Gabe S, Horslen S, Sudan D, Mazeriegos G, et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation 2008;85:1378-84. https://doi.org/10.1097/TP.0b013e31816dd513
  145. Javid PJ, Malone FR, Reyes J, Healey PJ, Horslen SP. The experience of a regional pediatric intestinal failure program: successful outcomes from intestinal rehabilitation. Am J Surg 2010;199:676-9. https://doi.org/10.1016/j.amjsurg.2010.01.013
  146. Grant D, Abu-Elmagd K, Mazariegos G, Vianna R, Langnas A, Mangus R, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant 2015;15:210-9. https://doi.org/10.1111/ajt.12979
  147. Norsa L, Gupte G, Ramos Boluda E, Joly F, Corcos O, Pirenne J, et al. Life of patients 10 years after a successful pediatric intestinal transplantation in Europe. Am J Transplant 2018;18:1489-93. https://doi.org/10.1111/ajt.14654
  148. Pironi L, Forbes A, Joly F, Colomb V, Lyszkowska M, Van Gossum A, et al. Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology 2008;135:61-71. https://doi.org/10.1053/j.gastro.2008.03.043
  149. Pironi L, Hebuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 2006;101:1633-43. https://doi.org/10.1111/j.1572-0241.2006.00710.x
  150. Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr 2012;31:831-45. https://doi.org/10.1016/j.clnu.2012.05.004
  151. Norsa L, Artru S, Lambe C, Talbotec C, Pigneur B, Ruemmele F, et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: parenteral nutrition or intestinal transplantation. Clin Nutr 2019;38:926-33. https://doi.org/10.1016/j.clnu.2018.02.004
  152. Taha AM, Sharif K, Johnson T, Clarke S, Murphy MS, Gupte GL. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:547-51. https://doi.org/10.1097/MPG.0b013e31823f42e7
  153. Sauvat F, Grimaldi C, Lacaille F, Ruemmele F, Dupic L, Bourdaud N, et al. Intestinal transplantation for total intestinal aganglionosis: a series of 12 consecutive children. J Pediatr Surg 2008;43:1833-8. https://doi.org/10.1016/j.jpedsurg.2008.03.028
  154. Lacaille F, Irtan S, Dupic L, Talbotec C, Lesage F, Colomb V, et al. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center. Transpl Int 2017;30:178-86. https://doi.org/10.1111/tri.12894
  155. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:753-71. https://doi.org/10.1086/676533
  156. Goulet OJ. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions. World Rev Nutr Diet 2015;112:90-114. https://doi.org/10.1159/000365604
  157. Abu-Elmagd K. The concept of gut rehabilitation and the future of visceral transplantation. Nat Rev Gastroenterol Hepatol 2015;12:108-20. https://doi.org/10.1038/nrgastro.2014.216

Cited by

  1. Intestinal failure in adults and children vol.112, 2019, https://doi.org/10.17235/reed.2020.6981/2020
  2. Lipid Emulsion Use in Pediatric Patients Requiring Long‐Term Parenteral Nutrition vol.44, pp.suppl1, 2020, https://doi.org/10.1002/jpen.1762
  3. Development and validation of an ambulatory piglet model for short bowel syndrome with ileo-colonic anastomosis vol.245, pp.12, 2019, https://doi.org/10.1177/1535370220915881
  4. Optimizing Nutritional Strategies to Prevent Necrotizing Enterocolitis and Growth Failure after Bowel Resection vol.13, pp.2, 2019, https://doi.org/10.3390/nu13020340
  5. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure vol.74, pp.3, 2019, https://doi.org/10.1016/j.jhep.2020.09.023
  6. Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome vol.40, pp.8, 2019, https://doi.org/10.1016/j.clnu.2021.07.017
  7. Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies vol.45, pp.7, 2019, https://doi.org/10.1002/jpen.2061
  8. Review article: insights into the bile acid‐gut microbiota axis in intestinal failure‐associated liver disease—redefining the treatment approach vol.55, pp.1, 2019, https://doi.org/10.1111/apt.16676